Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 493)
Posted On: 06/06/2022 12:50:18 AM
Post# of 154158
Posted By: ohm20
Re: craigakess #124223
It's listed right in that abstract.

Quote:
A total of n = 68 TEAEs were reported, with n = 7 grade I/II & n = 1 grade III related to leronlimab.



7 treatment-emergent adverse events grade 1 & 2. 1 is mild ae, 2 is moderate ae. 1 treatment-emergent adverse events grade 3, Grade 3 is a severe ae.













(3)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site